CSIMarket
 


Forty Seven Inc   (FTSV)
Other Ticker:  
 
 

FTSV's Revenue Growth by Quarter and Year

Forty Seven Inc 's Revenue results by quarter and year




FTSV Revenue (in millions $) FY 2019 FY 2018 FY 2017 FY 2016
IV Quarter December 0.00 0.00 0.00 0.00
III Quarter September 15.68 0.00 0.00 0.00
II Quarter June 0.00 0.00 0.00 0.00
I Quarter March 0.00 0.00 0.00 0.00
FY   15.68 0.00 0.00 0.00



FTSV Revenue fourth quarter 2019 Y/Y Growth Comment
Forty Seven Inc in the fourth quarter 2019 recorded of $ 0.00 millions.

According to the results reported in the fourth quarter 2019, Forty Seven Inc achieved the best Revenue growth in Major Pharmaceutical Preparations industry. While Forty Seven Inc ' s Revenue no change of % ranks overall at the positon no. in the fourth quarter 2019.




FTSV Revenue ( Y/Y Growth %) 2019
2018 2017 2016
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Forty Seven Inc 's fourth quarter 2019 Revenue $ 0.00 millions FTSV's Income Statement
Forty Seven Inc 's fourth quarter 2018 Revenue $ 0.00 millions Quarterly FTSV's Income Statement
New: More FTSV's historic Revenue Growth >>


FTSV Revenue (Quarter on Quarter Growth %)

2019
2018 2017 2016
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Revenue fourth quarter 2019 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Revenue fourth quarter 2019 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Revenue by Quarter for the Fiscal Years 2016, 2017, 2018, 2019

Forty Seven Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


FTSV's IV. Quarter Q/Q Revenue Comment
IV. Quarter 2019 accomplishment of 0.00 millions by Forty Seven Inc look even less good if you take a look at 15.68 millions in the previous quarter.

Within Major Pharmaceutical Preparations industry Forty Seven Inc achieved highest sequential Revenue growth. While Forty Seven Inc 's Revenue growth quarter on quarter, overall rank is .


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


FTSV's IV. Quarter Q/Q Revenue Comment
Current accomplishment of 0.00 millions by Forty Seven Inc come out even more unfavourable compare to the 15.68 millions in the previous quarter.

Within Major Pharmaceutical Preparations industry Forty Seven Inc achieved highest sequential Revenue growth. While Forty Seven Inc 's Revenue growth quarter on quarter, overall rank is .


Forty Seven Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Dec 31 2019)
12 Months Ending
(Sep 30 2019)
12 Months Ending
(Jun 30 2019)
12 Months Ending
(Mar 31 2019)
12 Months Ending
(Dec 31 2018)
Cumulative Revenue 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Revenue Growth (TTM) - - - - -
Year on Year Revenue Growth Overall Ranking # # # # #
Seqeuential Revenue Change (TTM) - - - - -
Seq. Revenue Growth (TTM) Overall Ranking # # # # #




Cumulative Revenue growth Comment
In the Dec 31 2019 period, Forty Seven Inc 's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Forty Seven Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Revenue growth Comment
In the Dec 31 2019 period, Forty Seven Inc 's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Forty Seven Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
FTSV's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for FTSV's Competitors
Revenue Growth for Forty Seven Inc 's Suppliers
Revenue Growth for FTSV's Customers

You may also want to know
FTSV's Annual Growth Rates FTSV's Profitability Ratios FTSV's Asset Turnover Ratio FTSV's Dividend Growth
FTSV's Roe FTSV's Valuation Ratios FTSV's Financial Strength Ratios FTSV's Dividend Payout Ratio
FTSV's Roa FTSV's Inventory Turnover Ratio FTSV's Growth Rates FTSV's Dividend Comparisons



Companies with similar Revenue no change for the quarter ending Dec 31 2019 within Healthcare SectorY/Y Change %Revenue for the quarter ending Dec 31 2019
Mannkind Corporation-0.24%$ -0.243 millions
Alpha Pro Tech Ltd -0.46%$ -0.456 millions
Amgen Inc -0.53%$ -0.530 millions
American Bio Medica Corporation-0.57%$ -0.566 millions
Ufp Technologies Inc -0.86%$ -0.862 millions
Heska Corporation-0.87%$ -0.872 millions
Orasure Technologies Inc-1.15%$ -1.150 millions
Atrion Corporation-1.32%$ -1.317 millions
Zoetis Inc -1.36%$ -1.355 millions
Titan Pharmaceuticals Inc -1.54%$ -1.537 millions
Global Cord Blood Corp-1.55%$ -1.548 millions
Dynatronics Corporation-1.57%$ -1.574 millions
Phibro Animal Health Corporation-1.93%$ -1.930 millions
Five Prime Therapeutics Inc -2.07%$ -2.074 millions
Magellan Health inc -2.28%$ -2.276 millions
Endo International Plc-2.75%$ -2.745 millions
Nighthawk Biosciences inc -2.87%$ -2.868 millions
Beigene ltd -3.03%$ -3.031 millions
Livanova Plc-3.16%$ -3.163 millions
Ironwood Pharmaceuticals inc -3.36%$ -3.360 millions
Accuray Incorporated-3.41%$ -3.413 millions
Arbutus Biopharma Corp-3.58%$ -3.576 millions
Encision Inc -3.71%$ -3.709 millions
Vascular Biogenics Ltd -3.93%$ -3.932 millions
Hutchmed china Limited-4.31%$ -4.306 millions
Cytomx Therapeutics Inc -4.45%$ -4.455 millions
Invacare Holdings Corporation-4.77%$ -4.769 millions
Community Health Systems Inc -4.84%$ -4.836 millions
Innoviva Inc -4.87%$ -4.867 millions
Stereotaxis Inc -5.16%$ -5.164 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com